CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 299 enrolled
Drug / intervention
Systane iLux® Dry Eye System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03956225
NCT03956225N/ACompleted
CompareCT.gov

Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study

Alcon Research·interventional·Posted May 20, 2019·Updated Oct 8, 2021

In Brief

A clinical study evaluating Systane iLux® Dry Eye System and LipiFlow® Thermal Pulsation System for Meibomian Gland Dysfunction and Evaporative Dry Eye Disease. Completed, enrolled 299 participants across 15 sites.

Detailed Summary

The purpose of this post-approval study is to demonstrate that iLux treatment offers comparable treatment effectiveness to LipiFlow for MGD treatment at 12 months post single treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMeibomian Gland Dysfunction, Evaporative Dry Eye Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 20, 2019
Enrollment StartJun 25, 2019
Primary CompletionOct 24, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.1 years ago

Interventions

Systane iLux® Dry Eye Systemdevice

Commercially available medical device intended for use by qualified eye care professionals to apply localized heat and pressure therapy to a patient's eyelids.

LipiFlow® Thermal Pulsation Systemdevice

Commercially available medical device intended for use by qualified eye care professionals to apply localized heat and pressure therapy to a patient's eyelids.